Sign In
Buy CNS
$80.79
-1.71 (-2.07%)
At Close: Jul 21, 2026
Cohen & Steers Appoints Jon Cheigh as President
08:00am, Tuesday, 17'th Dec 2024
NEW YORK , Dec. 17, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) has appointed Jon Cheigh as President, effective January 1, 2025. Mr. Cheigh remains Chief Investment Officer and will contin
Corero Network Security to Present at Microcap Conference
09:30am, Thursday, 12'th Dec 2024
MARLBOROUGH, MA / ACCESSWIRE / December 12, 2024 / Corero Network Security (LSE:CNS)(OTCQX:DDOSF), the distributed denial of service (DDOS) protection specialists is pleased to announce its participat
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For November 2024
04:22pm, Monday, 09'th Dec 2024
NEW YORK , Dec. 9, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $91.4 billion as of November 30, 2024, an increase of $1.7 billion from
Cohen & Steers Named a "Best Place to Work in Money Management" by Pensions & Investments for Fifth Consecutive Year
09:00am, Monday, 09'th Dec 2024
NEW YORK , Dec. 9, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that it has been named as one of the "Best Places to Work in Money Management" for the fifth consecutive year b
CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024
09:10am, Thursday, 05'th Dec 2024
Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion Leaders Company committed to addressing the most aggressive type of brain cancer with an average su
RNP: Predictable Income From Cohen & Steers
06:28pm, Tuesday, 26'th Nov 2024
Cohen & Steers REIT & Preferred Income Fund offers a consistent monthly dividend, is managed by a professional team, and is diversified across REITs, preferred stocks, and fixed income. The RNP closed
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
05:59pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources o
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
05:58pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of t
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
05:56pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the so
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
05:52pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources o
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
05:51pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dis
Poster presented at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024) Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first hal
CORERO NETWORK SECURITY TAPS INDUSTRY VETERAN JUDSON THUERK TO LEAD CHANNEL STRATEGY IN THE AMERICAS
07:00am, Monday, 25'th Nov 2024
MARLBOROUGH, Mass. , Nov. 25, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service (DDoS) protection specialists, announces the addition of Judso
HOUSTON, TX / ACCESSWIRE / November 18, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
09:10am, Friday, 15'th Nov 2024
Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025 Company strengthens cash position to extend runway to fund operations beyond da
